Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Samuel Yao Ahorhorlu"'
Autor:
Edward Kwakyi, Edmund Tetteh Nartey, Michael Kobina Otabil, Isaac Asiedu-Gyekye, Samuel Yao Ahorhorlu, Vincent Bioma, William Kudzi
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-7 (2024)
Abstract Background The burden of chronic kidney disease (CKD) and kidney failure in Ghana is on the ascendency, with the prevalence of CKD estimated at 13.3%. Patients with CKD who progress to kidney failure require life sustaining kidney replacemen
Externí odkaz:
https://doaj.org/article/be898f8afe6a4819b057b1591b27f990
Autor:
Catherine Segbefia, Seth Kwabena Amponsah, Adwoa K. A. Afrane, Mame Yaa Nyarko, Yvonne Brew, Nihad Salifu, Samuel Yao Ahorhorlu, Abdul Malik Sulley, Lars Hviid, Michael Fokuo Ofori, George Obeng Adjei
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionLimited information exists on any interactions between hydroxyurea (HU) and antimalarials in sickle cell disease (SCD). We evaluated changes in clinical and laboratory parameters among children with SCD on HU therapy treated with artemeth
Externí odkaz:
https://doaj.org/article/fd18e68c7be749a09284410242abbfe3
Autor:
Samuel Yao Ahorhorlu, Neils Ben Quashie, Rasmus Weisel Jensen, William Kudzi, Edmund Tetteh Nartey, Nancy Odurowah Duah-Quashie, Felix Zoiku, Bartholomew Dzudzor, Christian William Wang, Helle Hansson, Michael Alifrangis, George Obeng Adjei
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background Artemisinin-based combination therapy (ACT) is the first-line treatment for uncomplicated malaria in Ghana. Artemisinin (ART) tolerance in Plasmodium falciparum has arisen in Southeast Asia and recently, in parts of East Africa. T
Externí odkaz:
https://doaj.org/article/0f1bf3d93df0480cbd14c851c58ddac4
Autor:
John Lusingu, Susana Campino, Michael Alifrangis, Michael Theisen, Ole Lund, Tine Kliim Nydahl, Marina Crespo Bravo, Cally Roper, Subhash C. Singh, Helle H Hansson, Susheel K. Singh, Christian W. Wang, Samuel Yao Ahorhorlu, Manoj K. Das, Magatte Ndiaye
Publikováno v:
Nydahl, T K, Ahorhorlu, S Y, Ndiaye, M, Das, M K, Hansson, H, Bravo, M C, Wang, C W, Lusingu, J, Theisen, M, Singh, S K, Singh, S, Campino, S, Lund, O, Roper, C & Alifrangis, M 2021, ' Identification of single-nucleotide polymorphisms in the mitochondrial genome and kelch 13 gene of Plasmodium falciparum in different geographical populations ', American Journal of Tropical Medicine and Hygiene, vol. 105, no. 4, pp. 1085-1092 . https://doi.org/10.4269/ajtmh.21-0320
Am J Trop Med Hyg
Am J Trop Med Hyg
The emergence of artemisinin-resistant Plasmodium falciparum parasites in Southeast Asia threatens malaria control and elimination. The interconnectedness of parasite populations may be essential to monitor the spread of resistance. Combining a publi
Autor:
Samuel Yao Ahorhorlu, Neils Ben Quashie, Rasmus Weisel Jensen, William Kudzi, Edmund Tetteh Nartey, Nancy Odurowah Duah-Quashie, Felix Zoiku, Bartholomew Dzudzor, Christian William Wang, Helle Hansson, Michael Alifrangis, George Obeng Adjei
Background Artemisinin-based combination therapies (ACTs) are the first-line treatments for uncomplicated malaria in Ghana. Artemisinin (ART) tolerance in Plasmodium falciparum has arisen in Southeast Asia (SEA) and recently, in parts of East Africa.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68f6cfedd9ec0a7577182520ab6930ee
https://doi.org/10.21203/rs.3.rs-2300810/v1
https://doi.org/10.21203/rs.3.rs-2300810/v1
Autor:
Tine Kliim Nydahl, Samuel Yao Ahorhorlu, Ndiaye, Magatte, Das, Manoj Kumar, Hansson, Helle, Bravo, Marina Crespo, Wang, Christian William, Lusingu, John, Theisen, Michael, Singh, Susheel Kumar, Singh, Subhash, Campino, Susana, Lund, Ole, Roper, Cally, Alifrangis, Michael
Publikováno v:
American Journal of Tropical Medicine & Hygiene; Oct2021, Vol. 105 Issue 4, p1085-1092, 8p
Autor:
William Kudzi, Edmund T. Nartey, Richard H. Asmah, Edeghonghon Olayemi, Samuel Yao Ahorhorlu, Bartholomew Dzudzor
Publikováno v:
BMC Research Notes
Background Warfarin is a widely prescribed anticoagulant with narrow therapeutic window for thromboembolic events. Warfarin displays large individual variability in dose requirements. The purpose of this study is to assess the contribution of patient